Kim E. Dzobo

414 total citations
13 papers, 281 citations indexed

About

Kim E. Dzobo is a scholar working on Immunology, Surgery and Molecular Biology. According to data from OpenAlex, Kim E. Dzobo has authored 13 papers receiving a total of 281 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 6 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in Kim E. Dzobo's work include Atherosclerosis and Cardiovascular Diseases (7 papers), Lipoproteins and Cardiovascular Health (5 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Kim E. Dzobo is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (7 papers), Lipoproteins and Cardiovascular Health (5 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Kim E. Dzobo collaborates with scholars based in Netherlands, Belgium and United States. Kim E. Dzobo's co-authors include Jeffrey Kroon, Erik S.G. Stroes, Nick S. Nurmohamed, Menno P.J. de Winther, Jordan M Kraaijenhof, Johan G. Schnitzler, Arjen J. Cupido, Lotte C.A. Stiekema, Koen H.M. Prange and Sotirios Tsimikas and has published in prestigious journals such as Stroke, European Heart Journal and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Kim E. Dzobo

13 papers receiving 276 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kim E. Dzobo Netherlands	7	159	81	75	68	43	13	281
Alicia Gainza Spain	12	75 0.5×	92 1.1×	151 2.0×	87 1.3×	21 0.5×	21	317
Amaia García-Peña Spain	13	81 0.5×	102 1.3×	157 2.1×	97 1.4×	21 0.5×	18	332
Sven Bos Netherlands	10	279 1.8×	79 1.0×	132 1.8×	20 0.3×	102 2.4×	16	380
Ana Persson Sweden	6	60 0.4×	81 1.0×	67 0.9×	91 1.3×	74 1.7×	7	305
Lotfolah Saed Iran	6	87 0.5×	39 0.5×	38 0.5×	56 0.8×	41 1.0×	8	278
Kirsten Thiele Germany	6	65 0.4×	24 0.3×	53 0.7×	72 1.1×	23 0.5×	9	207
Rutger Verbeek Netherlands	9	341 2.1×	51 0.6×	164 2.2×	25 0.4×	83 1.9×	16	421
Feiming Ye China	10	37 0.2×	49 0.6×	107 1.4×	83 1.2×	29 0.7×	12	277
Katharina M. Scheurlen United States	12	154 1.0×	50 0.6×	18 0.2×	126 1.9×	96 2.2×	31	378

Countries citing papers authored by Kim E. Dzobo

Since Specialization

Citations

This map shows the geographic impact of Kim E. Dzobo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim E. Dzobo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim E. Dzobo more than expected).

Fields of papers citing papers by Kim E. Dzobo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim E. Dzobo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim E. Dzobo. The network helps show where Kim E. Dzobo may publish in the future.

Co-authorship network of co-authors of Kim E. Dzobo

This figure shows the co-authorship network connecting the top 25 collaborators of Kim E. Dzobo. A scholar is included among the top collaborators of Kim E. Dzobo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim E. Dzobo. Kim E. Dzobo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Hanford, K.J., Kim E. Dzobo, Miranda Versloot, Jorge Peter, & Jeffrey Kroon. (2025). Protocol to generate a 3D atherogenesis-on-chip model for studying endothelial-macrophage crosstalk in atherogenesis. STAR Protocols. 6(1). 103559–103559. 1 indexed citations

Dzobo, Kim E., Pascal Kusters, Nordin M.J. Hanssen, et al.. (2025). Accelerated atherosclerosis associated with immune checkpoint inhibitors: a systematic review and meta-analysis of pre-clinical studies. Atherosclerosis. 405. 119219–119219. 1 indexed citations

Dzobo, Kim E., Arjen J. Cupido, Lotte C.A. Stiekema, et al.. (2024). Diacylglycerols and Lysophosphatidic Acid, Enriched on Lipoprotein(a), Contribute to Monocyte Inflammation. Arteriosclerosis Thrombosis and Vascular Biology. 44(3). 720–740. 28 indexed citations

Kraaijenhof, Jordan M, Nick S. Nurmohamed, Kim E. Dzobo, et al.. (2024). Plasma C-reactive protein is associated with a pro-inflammatory and adverse plaque phenotype. Atherosclerosis. 396. 118532–118532. 6 indexed citations

Kaiser, Yannick, Kim E. Dzobo, Madeline J. L. Ravesloot, et al.. (2022). Reduced baroreflex sensitivity and increased splenic activity in patients with severe obstructive sleep apnea. Atherosclerosis. 344. 7–12. 5 indexed citations

Dzobo, Kim E., Jordan M Kraaijenhof, Erik S.G. Stroes, Nick S. Nurmohamed, & Jeffrey Kroon. (2022). Lipoprotein(a): An underestimated inflammatory mastermind. Atherosclerosis. 349. 101–109. 63 indexed citations

Itoh, Yoshifumi, Michael Ng, Akira Wiberg, et al.. (2021). A common SNP risk variant MT1-MMP causative for Dupuytren's disease has a specific defect in collagenolytic activity. Matrix Biology. 97. 20–39. 6 indexed citations

Dzobo, Kim E., et al.. (2021). Vascular Metabolism as Driver of Atherosclerosis: Linking Endothelial Metabolism to Inflammation. PubMed. 3(3). e210020–e210020. 18 indexed citations

Wasiak, Sylwia, Kim E. Dzobo, Brooke D. Rakai, et al.. (2020). BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes. Clinical Epigenetics. 12(1). 166–166. 31 indexed citations

10.

Stiekema, Lotte C.A., Koen H.M. Prange, Renate M. Hoogeveen, et al.. (2020). Potent lipoprotein(a) lowering following apolipoprotein(a) antisense treatment reduces the pro-inflammatory activation of circulating monocytes in patients with elevated lipoprotein(a). European Heart Journal. 41(24). 2262–2271. 77 indexed citations

11.

Waissi, Farahnaz, Mirthe Dekker, Nathalie Timmerman, et al.. (2020). Elevated Lp(a) (Lipoprotein[a]) Levels Increase Risk of 30-Day Major Adverse Cardiovascular Events in Patients Following Carotid Endarterectomy. Stroke. 51(10). 2972–2982. 15 indexed citations

12.

Schnitzler, Johan G., Kim E. Dzobo, Nick S. Nurmohamed, Erik S.G. Stroes, & Jeffrey Kroon. (2020). Surmounting the endothelial barrier for delivery of drugs and imaging tracers. Atherosclerosis. 315. 93–101. 5 indexed citations

13.

Neele, Annette E., Lisa Willemsen, Hung‐Jen Chen, Kim E. Dzobo, & Menno P.J. de Winther. (2020). Targeting epigenetics as atherosclerosis treatment: an updated view. Current Opinion in Lipidology. 31(6). 324–330. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact